Menter DG, Afshar-Kharghan V, Shen JP, Martch SL, Maitra A, Kopetz S , Honn KV, Sood AK
1 After hearing from the Akcea scientists, the people with FCS and Loris testimony, the advisory committee voted 12-8 in favor of recommending volanesorsens approval to the FDA
Studies are still ongoing to determine the cardiovascular effects of Tirzepatide
Possible reasons include the Washington State University patent holders not finding a pharmaceutical company willing to invest in development, the cancer biology concern with c-Met activation making development companies cautious, the preclinical effect sizes in rats not justifying the expense and risk of human trials, or other factors specific to drug development economics
Next, our care team undertakes the burdensome tasks of insurance verification and prior authorization
It is very easy to schedule, the staff is very knowledgeable and friendly and the overall experience is fantastic